----item----
version: 1
id: {2D24058F-1160-4272-8494-146FD58406C5}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/1995/02/06/Surgical sales and Ioptex drive Allergans growth
parent: {6EA0D371-3500-4D5E-93F0-ED628D5C61CD}
name: Surgical sales and Ioptex drive Allergans growth
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: bc5c2989-1f6d-40e0-834a-538b49ae0115

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 399

<p>Surgical ophthalmic sales at <strong>[C#198601285:Allergan]</strong> (US) rose 25% in fiscal 1994 compared with 1993. The rise was helped by the third- quarter purchase of Ioptex (US) from Smith & Nephew (UK); however, even excluding this acquisition, turnover increased 19%. Allergan says the launch of the AMO SI-30 intra-ocular lens and the AMO Prestige phacoemulsifier also boosted sales.</p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 49

Surgical sales and Ioptex drive Allergan's growth
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1167

<p>Surgical ophthalmic sales at <strong>[C#198601285:Allergan]</strong> (US) rose 25% in fiscal 1994 compared with 1993. The rise was helped by the third- quarter purchase of Ioptex (US) from Smith & Nephew (UK); however, even excluding this acquisition, turnover increased 19%. Allergan says the launch of the AMO SI-30 intra-ocular lens and the AMO Prestige phacoemulsifier also boosted sales.</p><pre>Allergan sales by division Three months Year ($ millions) 1994 1993 1994 1993 Eye care Pharmaceuticals 108.9 98.2 390.7 360.9 Surgical 47.7 34.1 144.3 115.3 Optical 90.6 82.4 339.4 325.0 Total eye care 247.2 214.7 874.4 801.2 Other 23.0 16.6 72.8 57.7 Total 270.2 231.3 947.2 858.9 Net profits 34.8 30.5 110.7 108.9 (ended December 31st)</pre><p>In a good start to 1995, Allergan has defeated a lawsuit filed against it and its surgical ophthalmic division, Allergan Medical Optics, by Staar Surgical (US). The Ninth Circuit Federal Court of Appeals affirmed earlier court judgements that Staar's case was without merit, says Allergan. The lawsuit dates from December 1991 and relates to several patent and technology cross-licences between the two companies.</p>
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 48

Surgical sales and Ioptex drive Allergans growth
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

19950206T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

19950206T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

19950206T000000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT051338
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 49

Surgical sales and Ioptex drive Allergan's growth
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 9

198601285
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

253107
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T183825Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

bc5c2989-1f6d-40e0-834a-538b49ae0115
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T183825Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
